By Ben Glickman DMK Pharmaceuticals Corp. named Seth Cohen as its next chief financial officer. The San Diego-based company, which is developing treatments.
By Josh Beckerman DMK Pharmaceuticals shares more than doubled, to $1.13, Tuesday as the company received a Canadian patent for an opioid intended to treat.